1. Home
  2. WBX vs PLRX Comparison

WBX vs PLRX Comparison

Compare WBX & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wallbox N.V.

WBX

Wallbox N.V.

N/A

Current Price

$2.76

Market Cap

63.8M

ML Signal

N/A

Logo Pliant Therapeutics Inc.

PLRX

Pliant Therapeutics Inc.

N/A

Current Price

$1.03

Market Cap

69.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WBX
PLRX
Founded
2015
2015
Country
Spain
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
63.8M
69.7M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
WBX
PLRX
Price
$2.76
$1.03
Analyst Decision
Hold
Hold
Analyst Count
2
6
Target Price
★ $4.00
$2.67
AVG Volume (30 Days)
12.3K
★ 353.8K
Earning Date
11-04-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 29.97
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$142.61
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.30
$0.97
52 Week High
$7.60
$1.95

Technical Indicators

Market Signals
Indicator
WBX
PLRX
Relative Strength Index (RSI) 42.51 37.32
Support Level $2.64 N/A
Resistance Level $3.12 $1.37
Average True Range (ATR) 0.15 0.04
MACD 0.00 -0.01
Stochastic Oscillator 54.10 25.00

Price Performance

Historical Comparison
WBX
PLRX

About WBX Wallbox N.V.

Wallbox NV is a smart electric vehicle charging and energy management company. It creates a smart charging system combining technology design that manages the communication between the user, vehicle, grid, building, and charger. The company designs, manufactures, and distributes faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments: Europe, the Middle East and Asia (EMEA), its key revenue-generating segment, North America, and Asia-Pacific.

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.

Share on Social Networks: